Cited by 1,763Cardiac pacing and defibrillation studiesCardiac Arrest and ResuscitationHeart Failure Treatment and Management

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Open access

Køber, Lars, Thune, Jens J., Nielsen, Jens C., Haarbo, Jens, Videbæk, Lars, Korup, Eva, Jensen, Gunnar, Hildebrandt, Per, Steffensen, Flemming H., Bruun, Niels E., Eiskjær, Hans, Brandes, Axel, Thøgersen, Anna M., Gustafsson, Finn, Egstrup, Kenneth, Videbæk, Regitze, Hassager, Christian, Svendsen, Jesper H., Høfsten, Dan E., Torp-Pedersen, Christian, Pehrson, Steen·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1608029

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The benefit of an implantable cardioverter-defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for a benefit of prophylactic ICDs in patients with systolic heart failure that is not due to coronary artery disease has been based primarily on subgroup analyses. The management of heart failure has improved since the landmark ICD trials, and many patients now receive cardiac resynchronization therapy (CRT). METHODS: In a randomized, controlled trial, 556 patients with symptomatic systolic heart failure (left ventricular ejection fraction, ≤35%) not caused by coronary artery disease were assigned to receive an ICD, and 560 patients were assigned to receive usual clinical care (control group). In both groups, 58% of the patients received CRT. The primary outcome of the trial was death from any cause. The secondary outcomes were sudden cardiac death and cardiovascular death. RESULTS: After a median follow-up period of 67.6 months, the primary outcome had occurred in 120 patients (21.6%) in the ICD group and in 131 patients (23.4%) in the control group (hazard ratio, 0.87; 95% confidence interval [CI], 0.68 to 1.12; P=0.28). Sudden cardiac death occurred in 24 patients (4.3%) in the ICD group and in 46 patients (8.2%) in the control group (hazard ratio, 0.50; 95% CI, 0.31 to 0.82; P=0.005). Device infection occurred in 27 patients (4.9%) in the ICD group and in 20 patients (3.6%) in the control group (P=0.29). CONCLUSIONS: In this trial, prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease was not associated with a significantly lower long-term rate of death from any cause than was usual clinical care. (Funded by Medtronic and others; DANISH ClinicalTrials.gov number, NCT00542945 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1608029

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A. H., Dyer, A. R., Daubert, J. P., Quigg, R. J., Estes, N. A. M., Anderson, K. P., Calkins, H. G., Hoch, D., Goldberger, J. J., Shalaby, A. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,078
Reduction in Inappropriate Therapy and Mortality through ICD Programming
Moss, A. J., Schuger, C. D., Beck, C. A., Brown, M. W., Cannom, D. S., Daubert, J. P., Estes, N. A. M., Greenberg, H., Hall, W. J., Huang, D. T.-C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211107 · Cited by 1,369

Flagged first, then by citations

Show all 18 references

Sorted by citations

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citation
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Zeppenfeld, K., Tfelt‐Hansen, J., Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,432
Self-citation
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Self-citation
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,356
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab364 · Cited by 2,019
Self-citation
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,902
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citation
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
Rangaswami, J., Bhalla, V., Blair, J. E., Chang, T. I., Costa, S. P., Lentine, K. L., Lerma, E. V., Mezue, K. N., Molitch, M. E., Müllens, W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000664 · Cited by 1,535
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2021) · EP Europace · doi:10.1093/europace/euab232 · Cited by 936
Self-citation
Heart Failure With Reduced Ejection Fraction: A Review
Murphy, S. P., Ibrahim, N. E., & Januzzi, J. L. (2020) · JAMA · doi:10.1001/jama.2020.10262 · Cited by 769
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 771
Dilated cardiomyopathy
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology
Seferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708
JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―
Tsutsui, H., Isobe, M., Ito, H., Ito, H., Okumura, K., Ōno, M., Kitakaze, M., Kinugawa, K., Kihara, Y., Goto, Y., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0342 · Cited by 720
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks
Fang, E. F., Xie, C., Schenkel, J. A., Wu, C., Long, Q., Cui, H., Aman, Y., Frank, J., Liao, J., Zou, H., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101174 · Cited by 717
Dilated cardiomyopathy
Weintraub, R. G., Semsarian, C., & Macdonald, P. S. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31713-5 · Cited by 676
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 644
Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology
Seferovic, P. M., Ponikowski, P. P., Anker, S. D., Bauersachs, J. K., Chioncel, O. D., Cleland, J. G. F., de Boer, R. A., Drexel, H., Gal, T. B., Hill, L., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1531 · Cited by 616
Declining Risk of Sudden Death in Heart Failure
Shen, L., Jhund, P. S., Petrie, M. C., Claggett, B. L., Barlera, S., Cleland, J. G. F., Dargie, H. J., Granger, C. B., KJEKSHUS, J. K., Køber, L., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609758 · Cited by 518
Self-citation
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2019) · EP Europace · doi:10.1093/europace/euz132 · Cited by 479
Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
Bauersachs, J. K., König, T., van der Meer, P., Petrie, M. C., Hilfiker‐Kleiner, D., Mbakwem, A. C., Hamdan, R., Jackson, A. M., Forsyth, P., de Boer, R. A., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1493 · Cited by 496
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.03.002 · Cited by 444
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018
Atherton, J. J., Sindone, A. P., Pasquale, C. G. D., Driscoll, A. L., Macdonald, P. S., Hopper, I., Kistler, P. M., Briffa, T. G., Wong, J., Abhayaratna, W. P., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1042 · Cited by 439
Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy
Marco, A. D., Anguera, I., Schmitt, M., Klem, I., Neilan, T. G., White, J. A., Šramko, M., Masci, P. G., Barison, A., McKenna, P. J., et al. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2016.09.017 · Cited by 425
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
Halliday, B. P., Gulati, A., Ali, A., Guha, K., Newsome, S., Aržanauskaitė, M., Vassiliou, V. S., Lota, A. S., İzgi, C., Tayal, U., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026910 · Cited by 386
Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology
Seferović, P. M., Polovina, M., Bauersachs, J., Arad, M., Ben Gal, T., Lund, L. H., Felix, S. B., Arbustini, E., Caforio, A. L. P., Farmakis, D., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1461 · Cited by 346
Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
Halliday, B. P., Baksi, A. J., Gulati, A., Ali, A., Newsome, S., İzgi, C., Aržanauskaitė, M., Lota, A. S., Tayal, U., Vassiliou, V. S., et al. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.07.015 · Cited by 336
Evolving Concepts in Dilated Cardiomyopathy
Merlo, M., Cannata, A. N., Gobbo, M., Stolfo, D., Elliot, P. M., & Sinagra, G. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1103 · Cited by 331
Ejection Fraction Pros and Cons
Marwick, T. H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2162 · Cited by 318
The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action
Marijon, É., Narayanan, K., Smith, K. L., Barra, S., Basso, C., Blom, M. T., Crotti, L., d’Ávila, A., Deo, R., Dumas, F., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00875-9 · Cited by 336
Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy
Patel, A. R., & Kramer, C. M. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2017.08.005 · Cited by 315
The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy
Becker, M. A. J., Cornel, J. H., van de Ven, P. M., van Rossum, A. C., Allaart, C. P., & Germans, T. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.03.006 · Cited by 300
Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society
Linde, C. M., Bongiorni, M. G., Birgersdotter-Green, U. M., Curtis, A. B., Deisenhofer, I., Furokawa, T., Gillis, A. M., Haugaa, K. H., Lip, G. Y. H., Gelder, I. C. V., et al. (2018) · EP Europace · doi:10.1093/europace/euy067 · Cited by 308
Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies
Wahbi, K., Yaou, R. B., Gandjbakhch, E., Anselme, F., Gossios, T. D., Lakdawala, N. K., Stalens, C., Sacher, F., Babuty, D., Trochu, J., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.039410 · Cited by 292
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches
Heymans, S. R. B., Lakdawala, N. K., Tschöpe, C., & Klingel, K. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01241-2 · Cited by 287
Highlights in Heart Failure
Tomasoni, D., Adamo, M., Lombardi, C., & Metra, M. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12555 · Cited by 286
Sudden Cardiac Death and Arrhythmias
Srinivasan, N. T., & SCHILLING, R. J. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018:15:2 · Cited by 249
Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure
Dey, S., DeMazumder, D., Sidor, A., Foster, D. B., & O'Rourke, B. P. (2018) · Circulation Research · doi:10.1161/circresaha.118.312708 · Cited by 245
Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy
Halliday, B. P., Cleland, J. G. F., Goldberger, J. J., & Prasad, S. K. (2017) · Circulation · doi:10.1161/circulationaha.116.027134 · Cited by 246
Heart failure with reduced ejection fraction
Bloom, M. W., Greenberg, B., Jaarsma, T., Januzzi, J. L., Lam, C. S. P., Maggioni, A. P., Trochu, J., & Butler, J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.58 · Cited by 239
ACC/AHA Versus ESC Guidelines on Heart Failure
van der Meer, P., Gaggin, H. K., & DEC, G. W. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.478 · Cited by 238
Cardiomyopathies: An Overview
Ciarambino, T., Menna, G., Sansone, G., & Giordano, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147722 · Cited by 250
Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., Oto, A., Potpara, T., Steffel, J., Marín, F. R., et al. (2017) · EP Europace · doi:10.1093/europace/eux091 · Cited by 233
Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study
Augusto, J. B., Eirós, R., Nakou, E. S., Ferreira, S. M., Treibel, T. A., Captur, G., Akhtar, M. M., Protonotarios, A., Gossios, T. D., Savvatis, K., et al. (2019) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jez188 · Cited by 214
Management of Arrhythmias in Cardiac Amyloidosis
Giancaterino, S., Urey, M. A., Darden, D. J., & Hsu, J. C. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.01.004 · Cited by 210
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0637 · Cited by 205
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 275
Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure
Elming, M. B., Nielsen, J. C., Haarbo, J., Videbæk, L. M., Korup, E., Signorovitch, J., Olesen, L. L., Hildebrandt, P. R., Steffensen, F. H., Bruun, N. E., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028829 · Cited by 190
Self-citation
Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy
Escobar-López, L., Ochoa, J. P., Mirelis, J. G., Espinosa, M. Á., Peñalver, M. N., Gallego‐Delgado, M., Villa, R. B., Mezcua, A. R., Basurte-Elorz, M. T., Gutiérrez, L., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.08.039 · Cited by 189
Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy
Marco, A. D., Brown, P. F., Bradley, J., Nucifora, G., Claver, E., de Frutos, F., Dallaglio, P., Colet, J. C., Anguera, I., Miller, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.030 · Cited by 190
Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices
Diego, C. D., González-Torres, L., Núñez, J. M., Inda, R. C., Martín-Langerwerf, D. A., Ferreyros, A. D. S., Chochowski, P., Casasnovas, P., Blazquéz, J. C., & Almendral, J. M. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.11.012 · Cited by 184
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Bansal, N., Adams, M. J., Ganatra, S., Colan, S. D., Aggarwal, S. A., Steiner, R. K., Amdani, S. M., Lipshultz, E. R., & Lipshultz, S. E. (2019) · Cardio-Oncology · doi:10.1186/s40959-019-0054-5 · Cited by 181
Role of titin in cardiomyopathy: from DNA variants to patient stratification
Ware, J. S., & Cook, S. A. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.190 · Cited by 176
Cardiovascular care with digital twin technology in the era of generative artificial intelligence
Thangaraj, P., Benson, S., Oikonomou, E. K., Asselbergs, F. W., & Khera, R. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae619 · Cited by 196
First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial
Tung, R. H., Xue, Y., Chen, M., Jiang, C., Shatz, D. Y., Besser, S. A., Hu, H., Chung, F.-P., Nakahara, S., Kim, Y.-H., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.060039 · Cited by 173
Arrhythmias in Patients ≥80 Years of Age
Curtis, A. B., Karki, R., Hattoum, A., & Sharma, U. C. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.019 · Cited by 180
JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12491 · Cited by 166
Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study
Zabel, M., Willems, R., Lubiński, A., Bauer, A., Brugada, J., Conen, D., Flevari, P., Hasenfuss, G. P., Svetlošák, M., Huikuri, H. V., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa226 · Cited by 161
Self-citation
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
Canepa, M., Fonseca, C., Chioncel, O., Laroche, C., Crespo‐Leiro, M. G., Coats, A. J. S., Mebazaa, A., Piepoli, M. F., Tavazzi, L., Maggioni, A. P., et al. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.02.001 · Cited by 159
Sudden Cardiac Death
Kuriachan, V. P., Sumner, G., & Mitchell, L. B. (2015) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2015.01.002 · Cited by 166
Optimized Implementation of Cardiac Resynchronization Therapy: A Call for Action for Referral and Optimization of Care
Müllens, W., Auricchio, A., Martens, P., Witte, K. K., Cowie, M., Delgado, V., Dickstein, K., Linde, C. M., Vernooy, K., Leyva, F., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2046 · Cited by 165
Self-citation
Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction
Martens, P., Nuyens, D., Rivero‐Ayerza, M., Herendael, H. V., Vercammen, J., Ceyssens, W., Luwel, E., Dupont, M., & Müllens, W. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01440-y · Cited by 155
Genetics and genomics of dilated cardiomyopathy and systolic heart failure
Tayal, U., Prasad, S. K., & Cook, S. A. (2017) · Genome Medicine · doi:10.1186/s13073-017-0410-8 · Cited by 161
Impact of Healthcare-Associated Infections Connected to Medical Devices—An Update
Dadi, N. C. T., Gaálová, B., Vargova, J., & Bujdáková, H. (2021) · Microorganisms · doi:10.3390/microorganisms9112332 · Cited by 163
Outcomes and Effect of Treatment According to Etiology in HFrEF
Balmforth, C., Simpson, J., Shen, L., Jhund, P. S., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K. B., et al. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.02.015 · Cited by 152
Sex- and Age-Based Differences in the Natural History and Outcome of Dilated Cardiomyopathy
Halliday, B. P., Gulati, A., Ali, A., Newsome, S., Lota, A. S., Tayal, U., Vassiliou, V. S., Aržanauskaitė, M., İzgi, C., Krishnathasan, K., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1216 · Cited by 148
Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients With Nonischemic Cardiomyopathy
Klem, I., Klein, M., Khan, M., Yang, E. Y., Nabi, F., Ivanov, A. V., Bhatti, L., Hayes, B. D., Graviss, E. A., Nguyen, D. T., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.048477 · Cited by 140
What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
Packer, M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz553 · Cited by 138
Myocardial fibrosis predicts ventricular tachyarrhythmias
Disertori, M., Masè, M., & Ravelli, F. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.01.011 · Cited by 134
Phenotype and Clinical Outcomes of Titin Cardiomyopathy
Tayal, U., Newsome, S., Buchan, R. J., Whiffin, N., Halliday, B. P., Lota, A. S., Roberts, A. M., Baksi, A. J., Voges, I., Midwinter, W., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.063 · Cited by 133
Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice
Baig, S., Edward, N. C., Kotecha, D., Liu, B., Nordin, S., Kozor, R., Moon, J., Geberhiwot, T., & Steeds, R. P. (2017) · EP Europace · doi:10.1093/europace/eux261 · Cited by 134
Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score
Younis, A., Goldberger, J. J., Kutyifa, V., Zaręba, W., Polonsky, B., Klein, H., Aktaş, M. K., Huang, D. T.-C., Daubert, J. P., Estes, M., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1057 · Cited by 132
Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy
Golwala, H. B., Bajaj, N. S., Arora, G., & Arora, P. K. (2016) · Circulation · doi:10.1161/circulationaha.116.026056 · Cited by 129
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.027 · Cited by 147
Myocardial fibrosis: why image, how to image and clinical implications
Bing, R., & Dweck, M. R. (2019) · Heart · doi:10.1136/heartjnl-2019-315560 · Cited by 127
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences
Verdonschot, J. A. J., Merlo, M., Domínguez, F., Wang, P., Henkens, M. T. H. M., Adriaens, M. E., Hazebroek, M. R., Masè, M., Escobar-López, L., Paz, R. C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa841 · Cited by 124
Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure
Schrage, B., Uijl, A., Benson, L., Westermann, D., Ståhlberg, M., Stolfo, D., Dahlström, U., Linde, C. M., Braunschweig, F., & Savarese, G. (2019) · Circulation · doi:10.1161/circulationaha.119.043012 · Cited by 121
ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing
Russo, A. M., Desai, M. Y., Do, M. M., Butler, J., Chung, M. K., Epstein, A. E., Guglin, M. E., Levy, W. C., Piccini, J. P., Bhave, N. M., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.11.023 · Cited by 128
Heart failure in the elderly.
Díez‐Villanueva, P., Jiménez-Méndez, C., & Alfonso, F. (2016) · PubMed Central · doi:10.11909/j.issn.1671-5411.2016.02.009 · Cited by 129
Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy
Alba, A. C., Gaztañaga, J., Foroutan, F., Thavendiranathan, P., Merlo, M., Alonso‐Rodríguez, D., Vallejo-García, V. E., Vidal-Pérez, R., Corros-Vicente, C., Barreiro‐Pérez, M., et al. (2020) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.119.010105 · Cited by 117
Self-citation
Alcoholic cardiomyopathy: What is known and what is not known
Mirijello, A., Tarli, C., Vassallo, G. A., Sestito, L., Antonelli, M., D’Angelo, C., Ferrulli, A., Cosmo, S. D., Gasbarrini, A., & Addolorato, G. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.06.014 · Cited by 116
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
Kitaoka, H., Tsutsui, H., Kubo, T., Ide, T., Chikamori, T., Fukuda, K., Fujino, N., Higo, T., Isobe, M., Kamiya, C., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0910 · Cited by 119
Update on heart failure management and future directions
Choi, H., Park, M., & Youn, J. (2018) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.428 · Cited by 117
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Bilchick, K. C., Wang, Y., Cheng, A., Curtis, J. P., Dharmarajan, K., Stukenborg, G. J., Shadman, R., Anand, I. S., Lund, L. H., Dahlström, U., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.568 · Cited by 113
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause
Rohde, L. E. P., Chatterjee, N. A., Vaduganathan, M., Claggett, B. L., Packer, M., Desai, A. S., Zile, M. R., Rouleau, J. L., Swedberg, K. B., Lefkowitz, M. P., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.06.015 · Cited by 109
Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar
Gutman, S., Costello, B. T., Papapostolou, S., Voskoboinik, A., Iles, L., Ja, J., Hare, J., Ellims, A., Kistler, P. M., Marwick, T. H., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy437 · Cited by 106
Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
Duncker, D., König, T., Hohmann, S., Bauersachs, J. K., & Veltmann, C. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004512 · Cited by 105
Management of cardiac sarcoidosis
Sharma, R. D., Kouranos, V., Cooper, L. T., Metra, M., Ristić, A. D., Heidecker, B., Baksi, J. A., Wicks, E. C., Merino, J. L., Klingel, K., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae356 · Cited by 106
Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy
Verdonschot, J. A. J., Hazebroek, M. R., Wang, P., Wijk, S. S., Merken, J. J., Adriaansen, Y. A., van den Wijngaard, A., Krapels, I. P. C., Rocca, H. B., Brunner, H. G., et al. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.118.005220 · Cited by 102
Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging
Donal, E., Delgado, V., Bucciarelli‐Ducci, C., Galli, E., Haugaa, K. H., Charron, P., Voigt, J., Cardim, N. M., Masci, P. G., Galderisi, M., et al. (2019) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jez178 · Cited by 105
Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects
Könemann, H., Dagres, N., Merino, J. L., Sticherling, C., Zeppenfeld, K., Tfelt‐Hansen, J., & Eckardt, L. (2023) · EP Europace · doi:10.1093/europace/euad091 · Cited by 105
Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials
Shun-Shin, M. J., Zheng, S. L., Cole, G. D., Howard, J. P., Whinnett, Z. I., & Francis, D. P. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx028 · Cited by 100
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy
Al‐Khatib, S. M., Fonarow, G. C., Joglar, J. A., Inoue, L. Y. T., Mark, D. B., Lee, K. L., Kadish, A. H., Bardy, G. H., & Sanders, G. D. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.0630 · Cited by 100
Sex Differences in Cardiac Arrhythmias
Ehdaie, A., Cingolani, E., Shehata, M. M., Wang, X., Curtis, A. B., & Chugh, S. S. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005680 · Cited by 100
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 105
Self-citation

Authors: Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., Eiskjær, H., Brandes, A., Thøgersen, A. M., Gustafsson, F., Egstrup, K., Videbæk, R., Hassager, C., Svendsen, J. H., Høfsten, D. E., Torp-Pedersen, C., & Pehrson, S.
Affiliations: University of Copenhagen (DK)
ORCID: Køber, Lars
Thune, Jens J.
Nielsen, Jens C.
Videbæk, Lars
Steffensen, Flemming H.
Bruun, Niels E.
Eiskjær, Hans
Brandes, Axel
Thøgersen, Anna M.
Gustafsson, Finn
Egstrup, Kenneth
Hassager, Christian
Svendsen, Jesper H.
Høfsten, Dan E.
Torp-Pedersen, Christian
Pehrson, Steen
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2016-09-29
Volume: 375
Issue: 13
Pages: 1221-1230
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1608029
OpenAlex: W2518530324
Cited by: 1,763
References: 18
Citations by year: 2026: 104 · 2025: 138 · 2024: 139 · 2023: 170 · 2022: 182 · 2021: 177 · 2020: 196 · 2019: 212 · 2018: 200 · 2017: 213 · 2016: 28
FWCI: 179.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, other-oa)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Scopus (Elsevier) (submittedVersion)
VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
Funders: Bristol-Myers Squibb
Pfizer
AstraZeneca
Sanofi
Gilead Sciences
Hjerteforeningen
Boston Scientific Corporation
TrygFonden
Servier
St. Jude Medical
Biosense Webster
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: implantable cardioverter-defibrillator, prophylactic ICD, heart failure with reduced ejection fraction, non-ischemic heart failure, sudden cardiac death, all-cause mortality, cardiac resynchronization therapy, device-related infection, left ventricular ejection fraction, DANISH trial
MeSH terms: Aged, Cardiac Pacing, Artificial, Cardiovascular Diseases, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mortality, Stroke Volume, Death, Sudden, Cardiac, Defibrillators, Implantable, Heart Failure, Systolic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks